Clinical trial · Observational
Retrospective Study of Germ Cell Tumors of the Central Nervous System
Single-center Retrospective Study of Germ Cell Tumors of the Central Nervous System
NCT05836701CI-TRIAL-00081539active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Retrospectively analyzing the epidemiological and clinical characteristics, treatment, recurrence, prognosis and prognostic factors of the germ-cell tumors of central nervous system in a single center.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Germ Cell Tumor of CNS | Central Nervous System Germ Cell Tumor | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (4)
- measure
- epidemiological characteristics
- timeFrame
- 1 year
- measure
- treatment regimen
- timeFrame
- 1 year
- measure
- relapse pattern
- timeFrame
- 1 year
- measure
- prognostic factor
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Clinically or pathologically diagnosed as germ cell tumor of the central nervous system. * Have received antitumor therapy. * Patients who were clinically diagnosed based on neuroimaging characteristics and response to radiotherapy or chemotherapy were allowed for enrollment. Exclusion Criteria: * Patients with missing key information such as tumor location, surgical, chemotherapy and radiotherapy data, and post-treatment evaluation.
References
Publications (0)
Data not yet available
No reference posted for this study.